| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09:59 | Nordic Semiconductor ASA: NOD: Invitation to fourth quarter results for 2025 | ||
| 08:29 | Orkla ASA: Status share buy-back programme | ||
| 08:29 | Lillestroem kommune: Euronext Oslo Børs - Lillestrøm kommune - Received application for listing of bonds | ||
| 08:29 | Questerre Energy Corporation: Insider ownership post corporate reorganization | ||
| Di | Kongsberg Gruppen ASA: KONGSBERG enter into agreement for purchase of own shares for Long-Term Incentive Plan | ||
| Di | Vow ASA: Expected non-cash accounting impairment | ||
| Di | INIFY Laboratories AB: Inify Laboratories - mandatory notification of trade | ||
| Di | INIFY Laboratories AB: Inify Laboratories - Final Results of the Repair Issue | ||
| Di | ENVIPCO HOLDING N.V.: Envipco Mandatory Notification of Trade | ||
| Di | Hospitality Invest AS: Completed tap issue | ||
| Di | ContextVision AB: Transactions made under the buy-back programme | ||
| Di | Desert Control AS: Financial calendar | ||
| Di | Kaldvik AS: Kaldvík AS: Appointment of interim CFO | ||
| Di | Lea Bank AB: Registration of share capital increase | ||
| Di | Å Energi AS: Å Energi: Successful issuance of new senior unsecured green NOK bonds | ||
| Di | Euronext Oslo Børs - Vestby kommune - Received application for listing of bonds | ||
| Di | Cambi ASA: Cambi signs THP engineering contract with PC Construction for a project in Virginia, USA | ||
| Di | Kid ASA - Invitation to presentation of Fourth quarter 2025 results | ||
| Di | Inin Group AS: ININ Group share buyback program status | ||
| Di | Arendals Fossekompani ASA: Q4 2025 financial results webcast and investor lunch with Volue | ||
| Di | 5th Planet Games A/S: 2-2026 5th Planet Games Shares Skybound Entertainment's Latest News for Invincible VS; More Fan-Favorite Invincible Characters Revealed! | ||
| Di | Ayfie International AS: Skien Municipality Signs AI Contract with Ayfie and Crayon | ||
| Di | Hynion AS: Restructuring update | ||
| Di | EXACT Therapeutics AS: EXACT Therapeutics: Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants | ||
| Di | Elliptic Laboratories ASA: Elliptic Labs initiates cost efficiency initiative following strategic review |